Long-Term Use Considerations

Levitra > levitra tablets 5mg


Avoid coadministration of ziftomenib with other drugs known to prolong the QTc interval. If unavoidable, obtain ECGs when initiating, during concomitant use, and as clinically indicated. Interrupt ziftomenib with QTc interval > 500 ms or a change from baseline is > 60 ms vardenafil and ziftomenib both increase QTc interval. Interrupt ziftomenib with QTc interval > 500 ms or a change from baseline is > 60 ms zotepinevardenafil increases effects of zotepine by pharmacodynamic synergism.

What is the risk associated with Levitra?

vardenafil increases effects of phenoxybenzamine by pharmacodynamic synergism. phentolaminevardenafil increases effects of phentolamine by pharmacodynamic synergism. vardenafil increases effects of phentolamine by pharmacodynamic synergism. prazosinvardenafil increases effects of prazosin by pharmacodynamic synergism. vardenafil increases effects of prazosin by pharmacodynamic synergism.

Dosage Modifications

ribociclibribociclib increases toxicity of vardenafil by QTc interval. ribociclib increases toxicity of vardenafil by QTc interval. rifabutinrifabutin will decrease the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. rifabutin will decrease the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. rifampinrifampin will decrease the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism.

What is vardenafil, and what is it used for?

rifampin will decrease the level or liquid levitra effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. sevofluranesevoflurane and vardenafil both increase QTc interval. sevoflurane and vardenafil both increase QTc interval. silodosinvardenafil increases effects of silodosin by pharmacodynamic synergism. vardenafil increases effects of silodosin by pharmacodynamic synergism. vardenafil increases effects of zotepine by pharmacodynamic synergism. adagrasibadagrasib will increase the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism.

Product Dosage Quantity + Bonus Price
Levitra Generic60mg30 + 2 Pills109.43€ 104.22€
Levitra Professional20mg20 Pills101.00€ 96.19€
Levitra Professional20mg120 + 4 Pills348.44€ 331.85€
Levitra Soft Tabs20mg10 Pills52.27€ 49.78€
Levitra Generic40mg30 + 2 Pills93.58€ 89.12€
Levitra Generic40mg10 Pills41.37€ 39.40€
Levitra Generic10mg90 + 8 Pills150.58€ 143.41€
Levitra Soft Tabs20mg120 + 8 Pills288.52€ 274.78€
Levitra Original20mg22 + 2 Pills138.55€ 131.95€
Levitra Generic10mg270 + 10 Pills338.09€ 321.99€
Levitra Professional20mg60 + 2 Pills223.11€ 212.49€
Levitra Generic10mg20 Pills46.54€ 44.32€
Levitra Generic40mg120 + 8 Pills302.37€ 287.97€
Levitra Professional20mg360 + 6 Pills914.63€ 871.08€
Levitra Generic20mg180 + 10 Pills293.10€ 279.14€
Levitra Original20mg34 + 2 Pills188.51€ 179.53€

Vardenafil dose may need to be reduced if coadministered with moderate or strong CYP3A4 inhibitors adagrasib will increase the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Vardenafil dose may need to be reduced if coadministered with moderate or strong CYP3A4 inhibitors alfuzosinvardenafil and alfuzosin both increase QTc interval. Use Caution/Monitor.alfuzosin and vardenafil both increase QTc interval. vardenafil and alfuzosin both increase QTc interval. Monitor blood pressure response to phosphodiesterase type 5 (PDE5) inhibitors in patients receiving concurrent blood pressure lowering therapy. amiodaroneamiodarone will increase the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Vardenafil dose may need to be reduced if coadministered with moderate or strong CYP3A4 inhibitors amiodarone will increase the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism.

More about Levitra (vardenafil)

siponimod and vardenafil both increase QTc interval. St John's WortSt John's Wort will decrease the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. St John's Wort will decrease the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. terazosinvardenafil increases effects of terazosin by pharmacodynamic synergism. vardenafil increases effects of terazosin by pharmacodynamic synergism.

Does vardenafil interact with other medicines (drug interactions)?

tetrabenazinetetrabenazine and vardenafil both increase QTc interval. tetrabenazine and vardenafil both increase QTc interval. tovorafenibtovorafenib will decrease the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Avoid coadministration of tovorafenib (a weak CYP3A4 inducer) with CYP3A substrates where minimal concentration changes may lead to serious therapeutic failures. If unavoidable, monitor patients for loss of efficacy unless otherwise recommended in the CYP3A4 substrate prescribing information. Vardenafil dose may need to be reduced if coadministered with moderate or strong CYP3A4 inhibitors apomorphineapomorphine and vardenafil both increase QTc interval. apomorphine and vardenafil both increase QTc interval. aprepitantaprepitant will increase the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism.

  • Levitra 5mg can improve confidence and sexual satisfaction.
  • It is not an aphrodisiac; sexual stimulation is required.
  • If an erection lasts more than 4 hours, seek emergency medical help.
  • Regular exercise and a healthy diet can enhance treatment effects.
  • Levitra 5mg can be part of a comprehensive ED management plan.

Vardenafil dose may need to be reduced if coadministered with moderate or strong CYP3A4 inhibitors aprepitant will increase the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism.

Warnings of Levitra and Cialis

macimorelinmacimorelin and vardenafil both increase QTc interval. Macimorelin causes an increase of ~11 msec in the corrected QT interval. Avoid coadministration with drugs that prolong QT interval, which could increase risk for developing torsade de pointes-type ventricular tachycardia. Allow sufficient washout time of drugs that are known to prolong the QT interval before administering macimorelin. macimorelin and vardenafil both increase QTc interval.

What should I tell my healthcare provider before taking vardenafil?

mefloquinemefloquine increases toxicity of vardenafil by QTc interval. Mefloquine may enhance the QTc prolonging effect of high risk QTc prolonging agents. mefloquine increases toxicity of vardenafil by QTc interval. vardenafil and milsaperidone both increase QTc interval. moxisylytevardenafil increases effects of moxisylyte by pharmacodynamic synergism.

Other Medical Problems

vardenafil increases effects of moxisylyte by pharmacodynamic synergism. ondansetronondansetron and vardenafil both increase QTc interval. ondansetron and vardenafil both increase QTc interval. oxaliplatin and vardenafil both increase QTc interval. phenoxybenzaminevardenafil increases effects of phenoxybenzamine by pharmacodynamic synergism. Vardenafil dose may need to be reduced if coadministered with moderate or strong CYP3A4 inhibitors aripiprazolearipiprazole and vardenafil both increase QTc interval. aripiprazole and vardenafil both increase QTc interval. armodafinilarmodafinil will decrease the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism.

  • Common side effects of Levitra 5mg include dizziness and nasal congestion.
  • Levitra 5mg does not cure ED but helps achieve an erection.
  • Do not take Levitra 5mg if allergic to vardenafil.
  • Avoid grapefruit or grapefruit juice when taking Levitra 5mg.
  • Levitra 5mg should not be used with other ED medications.

armodafinil will decrease the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. artemether/lumefantrineartemether/lumefantrine will decrease the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism.

Shipping Information

givinostatvardenafil and givinostat both increase QTc interval. If unable to avoid coadministration, obtain ECGs when initiating, during concomitant use, and as clinically indicated. Withhold if QTc interval >500 ms or a change from baseline >60 ms. vardenafil and givinostat both increase QTc interval. hydroxychloroquine sulfate and vardenafil both increase QTc interval.

What else should I know about vardenafil?

idelalisibidelalisib will increase the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Idelalisib is a strong CYP3A inhibitor; avoid coadministration with sensitive CYP3A substrates idelalisib will increase the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Idelalisib is a strong CYP3A inhibitor; avoid coadministration with sensitive CYP3A substrates iloperidonevardenafil and iloperidone both increase QTc interval. isoflurane and vardenafil both increase QTc interval. itraconazoleitraconazole and vardenafil both increase QTc interval.

How should I store vardenafil?

itraconazole and vardenafil both increase QTc interval. Avoid coadministration of QTc prolonging drugs with ivosidenib or replace with alternate therapies. Avoid coadministration of sensitive CYP3A4 substrates with ivosidenib or replace with alternative therapies. If coadministration is unavoidable, monitor patients for loss of therapeutic effect of these drugs. If coadministration of a QTc prolonging drug is unavoidable, monitor for increased risk of QTc interval prolongation. artemether/lumefantrine will decrease the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism.

Key takeaways

tovorafenib will decrease the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. tucatinibtucatinib will increase the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Avoid concomitant use of tucatinib with CYP3A substrates, where minimal concentration changes may lead to serious or life-threatening toxicities. If unavoidable, reduce CYP3A substrate dose according to product labeling. tucatinib will increase the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. asenapinevardenafil increases effects of asenapine by pharmacodynamic synergism.

  • Levitra 5mg can improve sexual performance for some men.
  • No need to take Levitra 5mg daily, only before sexual activity.
  • Store Levitra 5mg tablets away from heat and moisture.
  • Contact a healthcare provider if you experience sudden vision loss.
  • Levitra 5mg may cause priapism, which requires urgent treatment.

vardenafil increases effects of asenapine by pharmacodynamic synergism. atazanaviratazanavir will increase the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism.

Attribute Description Notes
Active Ingredient Vardenafil PDE5 inhibitor
Dosage Form Tablet 5mg dosage
Manufacturer Bayer Pharmaceuticals Approved by FDA
Use Duration Typically effective within 30-60 minutes Onset of action
Typical Course Taken as needed, not regularly Consult doctor for guidance

Limit vardenafil dose to 2.5 mg/24 hr atomoxetineatomoxetine and vardenafil both increase QTc interval. atomoxetine and vardenafil both increase QTc interval. bedaquilinevardenafil and bedaquiline both increase QTc interval.

  • Levitra 5mg may be effective for men with diabetes-related ED.
  • Do not abruptly stop using Levitra 5mg without consulting your doctor.
  • Combining Levitra 5mg with certain antidepressants may cause adverse effects.
  • The medication is non-physical addictive but should be used responsibly.
  • Results may vary based on individual health and dosage adherence.

vardenafil and bedaquiline both increase QTc interval.

Coverage and cost comparison of Levitra vs. Cialis

Exercise extreme caution when vilanterol coadministered with drugs that prolong QTc interval; adrenergic agonist effects on the cardiovascular system may be potentiated. vardenafil increases toxicity of umeclidinium bromide/vilanterol inhaled by QTc interval. Concomitant use of vemurafenib with drugs that prolong QT interval is not recommended. vilanterol/fluticasone furoate inhaledvardenafil increases toxicity of vilanterol/fluticasone furoate inhaled by QTc interval. vardenafil increases toxicity of vilanterol/fluticasone furoate inhaled by QTc interval. Either increases effects of the other by Mechanism: pharmacodynamic synergism. bicalutamidebicalutamide will increase the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism.

Parameter Value Notes
Absorption Rapid, peak plasma levels in 60 minutes Food may delay absorption
Bioavailability Approximately 12-45% Varies among individuals
Half-life About 4-5 hours Duration of effect
Metabolism Liver (CYP3A4 enzyme) Adjust dose if liver impairment

Vardenafil dose may need to be reduced if coadministered with moderate or strong CYP3A4 inhibitors bicalutamide will increase the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism.